Abstract: In a reforming apparatus, for use in a fuel cell, for reforming a raw fuel into a hydrogen-rich reformed gas, a reformer generates the reformed gas from the raw fuel. A shift reactor reduces carbon monoxide contained in the reformed gas through a shift reaction. A selective oxidation unit reduces the carbon monoxide contained in the reformed gas that has passed through the shift reactor by performing selective oxidation on the carbon monoxide. A reforming reaction tube houses linearly the reformer, the shift reactor and the selective oxidation unit in this order.

Abstract: An air-conditioning management apparatus is capable of selecting an air-conditioning device that affects an air-conditioning environment at a specific position in an air-conditioned space from a plurality of air-conditioning devices. An area that is within an air-conditioned space to which a specific position P belongs in an arrangement plan and that is within a predetermined range from the specific position is obtained as a control target range. An air-conditioning device whose installation position in the arrangement plan is included in the control target range is selected as a control target air-conditioning device.

Abstract: A high frequency signal interpolation apparatus provides, with a simple structure, a high-quality digital audio signal through interpolation of high frequency signals missing due to compression. The high frequency signal interpolation apparatus includes a peak value detection and holding circuit configured to detect a peak value of a digital audio signal provided to an input terminal by sampling the digital audio signal and generate a square wave signal by holding the detected peak value; a high-pass filter configured to extract a higher harmonic component from the generated square wave signal; and an adder configured to add the extracted higher harmonic component to the digital audio signal provided to the input terminal.

Abstract: An apparatus is provided for providing users diagnosis on driving operations in the same manner as diagnosing vehicle failures and for presenting evaluation with supporting data so that users may recognize their driving operations. The apparatus reads out driving data for a plurality of driving cycles from an electronic control unit on board the vehicle. The electronic control unit includes a memory for storing driving data representing fuel efficiency condition of the vehicle in accordance with driving operation by a user in each driving cycle of the vehicle. Charts are produced representing fuel efficiency condition for each driving operation by the user for each driving cycle, based on the read out driving data. The charts are output as comparison results for each one of the driving cycles.

Abstract: An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.

Abstract: In the fuel cell system, a change in a voltage from a cell stack in relation to a fuel utilization rate is acquired and deterioration of the cell stack is detected by comparing a value of the voltage with a reference value. Moreover, when it is determined that the cell stack has deteriorated, the rated power of the system is decreased so that the fuel cell system operates according to the deterioration state of the cell stack.

Abstract: The invention provides an organic compound(s) hydrogenation device that allows hydrogen derived from water to be stored essentially without generating hydrogen gas. The organic compound hydrogenation device of the invention comprises an oxidation chamber that holds a water-containing electrolyte, a reduction chamber that holds an organic compound(s) with an unsaturated bond, an electrolyte membrane with ion permeability that separates the electrolyte held in the oxidation chamber from the organic compound(s) held in the reduction chamber, an oxidizing electrode that generates protons from the water held in the oxidation chamber, and a reducing electrode that hydrogenates the organic compound(s) held in the reduction chamber.

Abstract: An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.

Abstract: A vehicle failure is diagnosed based on data recorded in an electronic control unit (ECU) of a vehicle. Driving data pertaining to multiple parameters which are stored in the electronic control unit of the vehicle for when a vehicle failure occurs are compared with reference values representing data during normal driving in order to diagnose a failure. The device utilizes an approximate search between inspection data, that is, driving data which are stored in the electronic control unit of the vehicle to be diagnosed for failure, and reference value groups categorized by driving environment, wherein a normal value range is set for each of the aforementioned parameters categorized by driving environment, and selects the reference value group categorized by driving environment which approximates the inspection data.

Abstract: There is provided a slide fastener including a pair of fastener stringers in which a plurality of fastener elements, are attached to opposing one-side edges of a pair of fastener tapes each of which is formed by coating a woven and tape-shaped core material with a coating material to form respective fastener element rows, and a slider slidably attached to the fastener element rows to engage and disengage the fastener elements. The tape-shaped core material is formed with a plurality of holes penetrating in a front back direction thereof the holes disposed at positions outer than the fastener elements in a width direction and arranged along a longitudinal direction of the fastener tapes. An edge of the each of the holes is molten, and the coating material is formed so as to cove the plurality of holes.

Abstract: A signal corresponding to a short-period change and a signal corresponding to a long-period change of a sound signal are detected, and optimal quantization is performed based on the combination of the two signals. In an ADPCM encoding apparatus (100), a differential value dn between a 16-bit input signal Xn and a decoded signal Yn-1 of one sample ago is calculated by a subtractor (102). Thereafter, the 16-bit differential value dn is adaptively quantized by an adaptive quantizing section (103), so as to be converted to a (1 to 8)-bit length-variable ADPCM value Dn. Thereafter, the ADPCM value Dn is compression-encoded by a compression-encoding section (108) to generate a signal D?n, and the signal D?n is framed by a framing section (130) and outputted. Further, in an ADPCM decoding apparatus, a framed input signal is subjected to a reverse of the aforesaid process so as to be decoded.

Abstract: A pyrochlore-type oxide represented by a general formula A2B2O7-Z is prepared by precipitate formation, where A and B each represent a metal element, where Z represents a number of at least 0 and at most 1, where A contains at least one element selected from a group consisting of Pb, Sn, and Zn, and where B contains at least one element selected from a group consisting of Ru, W, Mo, Ir, Rh, Mn, Cr, and Re. Impurities are then sufficiently removed through washing and drying processes, and the pyrochlore-type oxide is calcined under controlled conditions. This allows the crystallinity of the pyrochlore-type oxide, which contained amorphous parts immediately after the production of the precipitate, to be increased so that the resistance to acid can be improved while preventing particle aggregation.

Abstract: An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.

Abstract: The present invention provides a method for preparing a pyrochlore type oxide having a larger specific surface area, a polymer electrolyte fuel cell and a fuel cell system improved in power generation efficiency and capable of being produced more inexpensively, and a method for producing an electro catalyst for a fuel cell, which electro catalyst has a larger specific surface area, is relatively inexpensive, and has high electrode activity per unit mass. A method for preparing a pyrochlore type oxide represented by A2B2O7-Z wherein A and B represent a metal element, Z represents a number of 0 or more and 1 or less, A includes at least one selected from the group consisting of Pb, Sn, and Zn, and B includes at least one selected from the group consisting of Ru, W, Mo, Ir, Rh, Mn, Cr, and Re, wherein the pyrochlore type oxide is produced by a reaction of a halide or nitrate of A with an alkali salt of a metal acid of B.

Abstract: To obtain a control system of an air conditioning system capable of easily confirming a set content of an interlocking control. A simulation device that generates simulation operation information simulating an interlock operation of facility devices based on interlock settings information, a display controller that makes a display device display a layout plan and the simulation operation information in accordance with the display of the facility devices in the layout plan.

Abstract: A favorable high-frequency signal is generated and practical high-frequency signal interpolation is implemented through simple processing. A digital audio signal reproduced by an instrument, which also carries out compression, is supplied as an original signal to an input terminal 1, and this original signal is then supplied to a digital sample and hold circuit 3 via a band-pass filter 2. The signal from the digital sample and hold circuit 3 is supplied to a ±1 multiplier 6, which then alternately inverts sign bits. The harmonic components of this signal in which the sign bits are inverted alternately are extracted by a high-pass filter (HPF) 7. Meanwhile, the original signal from the input terminal 1 is supplied to a delay circuit 8 equivalent to the processing time consumed by the aforementioned digital sample and hold circuit 3 and related circuits, forming an adjusted, delayed signal.

Abstract: The present invention provides an apparatus which displays a plan wiring diagram and three-dimensional layout diagram by associating them with each other so that they can be viewed easily. A apparatus for displaying wiring includes a first storage for storing an image of a plan wiring diagram which shows parts and wirings and a second storage for storing a three-dimensional layout of an apparatus which incorporates the parts and the wirings, and a third storage for storing intermediate images transitional between a starting image in the plan wiring diagram and an ending image of a shape of the corresponding wiring in the three-dimensional layout. A processor displays the plan wiring diagram on the display device by retrieving the plan wiring diagram from the first storage based on a user's selection, and retrieves the intermediate images of a wiring from the third storage when the wiring is selected from the plan wiring diagram and displays transitions to the shape shown in the three-dimensional layout.

Abstract: In a reforming apparatus, for use in a fuel cell, for reforming a raw fuel into a hydrogen-rich reformed gas, a reformer generates the reformed gas from the raw fuel. A shift reactor reduces carbon monoxide contained in the reformed gas through a shift reaction. A selective oxidation unit reduces the carbon monoxide contained in the reformed gas that has passed through the shift reactor by performing selective oxidation on the carbon monoxide. A reforming reaction tube houses linearly the reformer, the shift reactor and the selective oxidation unit in this order.

Abstract: An acoustic characteristic control apparatus supplies music signal, for example, to input terminal connected to a band-pass filter and a peaking filter. In a zero-cross detection circuit, a pulse signal corresponding to a period while a signal is positive is formed. A pulse-width measuring circuit output a signal corresponding to a pulse width. Next, the output of the pulse-width measuring circuit is inputted to one comparator and another comparator. The one comparator discriminates a time when the pulse width is equal to or larger than a first setting value, and the another comparator discriminates a time when the pulse width is equal to or smaller than a second setting value. The comparator is connected to the up terminal and the down terminal of an up/down counter. The output of the up/down counter is connected to the peaking filter through the subtractor, and acoustic characteristics of the peaking filter is controlled according to the count value of the up/down counter.

Abstract: An astrocyte-specific drug carrier containing a retinoid derivative and/or a vitamin A analog as a constituent; a drug delivery method with the use of the same; a drug containing the same; and a therapeutic method with the use of the drug. By binding a drug carrier to a retinoid derivative such as vitamin A or a vitamin A analog or encapsulating the same in the drug carrier, a drug for therapeutic use can be delivered specifically to astrocytes. As a result, an astrocyte-related disease can be efficiently and effectively inhibited or prevented while minimizing side effects. As the drug inhibiting the activity or growth of astrocytes, for example, a siRNA against HSP47 which is a collagen-specific molecule chaperone may be encapsulated in the drug carrier. Thus, the secretion of type I to type IV collagens can be inhibited at the same time and, in its turn, fibrosis can be effectively inhibited.